Untitled

CanCURE at the Towards an HIV Cure Symposium & the AIDS 2016 Conference in Durban

July 22, 2016

CanCURE members will be attending the 2016 Towards an HIV Cure Symposium on July 16-17 and the 21st International AIDS Conference (AIDS 2016) on July 18-22 in Durban, South Africa. CanCURE Investigators, Trainees and Community Advisors will present their work during various oral sessions and poster exhibitions at both these meetings.

Below is a roadmap of presentations by CanCURE members at the Towards an HIV Cure Symposium and the AIDS 2016 Conference, both to be held at the Durban International Convention Centre (ICC). 

 

2016 TOWARDS AN HIV CURE SYMPOSIUM (July 16-17 in Session Room 11 of the ICC, read the Symposium program here >>):

  • Éric A. Cohen  “Enhancing HIV-1 virion tethering by BST2/Tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies”  Oral presentation, July 17 (10h05) Program #OA2-4 

  • Jean-Pierre Routy  “HIV persists in colon and blood CCR6+CD4+ T-cells during ART” Oral presentation, July 17 (16h00) Program #OA4-2

  • Xiaomei Tallie Kuang (from CanCURE member Mark Brockman’s lab)  “Effects of HDACi on T cell activation and HIV latency reversal” Poster presentation during exhibitions on July 16 (18h00 - 19h30) & July 17 (12h35 - 14h00)

  • Jean-Pierre Routy  “Alarmin IL-33/ST2 pathway as an inductor of T-cell dependent response in acute and early HIV-infected patients” Poster presentation during exhibitions on July 16 (18h00 - 19h30) & July 17 (12h35 - 14h00)

  • Ian Tietjen (du labo du membre CanCURE Mark Brockman)  “Novel activators and suppressors of latent HIV-1 from natural products” Poster presentation during exhibitions on July 16 (18h00 - 19h30) & July 17 (12h35 - 14h00)

  • Emmanuelle Wilhelm (from CanCURE member Brendan Bell’s lab)  “Identification of a new host cell HDAC complex that controls HIV latency through direct binding to the core promoter”  Poster presentation during exhibitions on July 16 (18h00 - 19h30) & July 17 (12h35 - 14h00)

AIDS 2016 CONFERENCE (July 18-22 at the ICC, view the Conference program here >>):​

  • Emmanuelle Wilhelm (from CanCURE member Brendan Bell’s lab) “Identification of a new host cell HDAC complex that controls HIV latency through direct binding to the core promoter” Poster presentation during exhibition on July 19 (12h30 - 14h30) Program #TUPEA014 >>​

  • Robert Reinhard  “Engaging in HIV Cure research: Understanding current and future scientific and clinical challenges” Co-facilitator during this scientific workshop on July 19 (14h30) Session Room 3, Session Code TUWS07 >>

  • Éric A. Cohen  “Enhancing HIV-1 virion tethering by BST2/Tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies”  Poster presentation during exhibition on July 20 (12h30 - 14h30) Program #WEPEA023 >>​

  • Ian Tietjen (from CanCURE member Mark Brockman’s lab) “Novel activators and suppressors of latent HIV-1 from natural products" Poster presentation during exhibition on July 20 (12h30 - 14h30) Program #WEPEA025 >>​

  • Jean-Pierre Routy (presenting on behalf of CanCURE member Petronela Ancuta) “HIV persists in colon and blood CCR6+CD4+ T-cells during ART” Oral poster discussion on July 21 (13h05) Session Room 10, Program #THPDA0102 >>​​​​

 

 

Please reload

Rejoignez-nous! Événement CanCURE le 8 novembre au IRCM

October 17, 2019

Join us! CanCURE Public Event on November 8th @ IRCM

October 17, 2019

CanCURE à la conférence de l'IAS sur la science du VIH, Mexico, 2019

July 19, 2019

1/2
Please reload

©2019 CanCURE

Follow

  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon